Trial intelligence / Profile preview

Esketamine in Perioperative Period of Puerpera

ChiCTR2100052668Phase 4Recruiting

Sponsor
The Fourth Hospital of Shijiazhuang
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative pain and postpartum depression (PPD) (3 arms), sponsored by The Fourth Hospital of Shijiazhuang. Primary endpoints: Patient Health Questionnaire-9 score, Heart rate and 2 more. Started Nov 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

postoperative painpostpartum depression (PPD)

Beyond the preview

Go deeper on ChiCTR2100052668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call